Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation.

The oncologist 2022 Aug 05

filter terms:

In the current study, we examined the real-world prevalence of highly pigmented advanced melanomas (HPMel) and the clinicopathologic, genomic, and ICPI biomarker signatures of this class of tumors. Our case archive of clinical melanoma samples for which the ordering physician requested testing for both PD-L1 immunohistochemistry (IHC) and comprehensive genomic profiling (CGP) was screened for HPMel cases, as well as for non-pigmented or lightly pigmented advanced melanoma cases (LPMel). Of the 1268 consecutive melanoma biopsies in our archive that had been submitted for PD-L1 IHC, 13.0% (165/1268) were HPMel and 87.0% (1103/1268) were LPMel. In the HPMel cohort, we saw a significantly lower tumor mutational burden (TMB, median 8.8 mutations/Mb) than in the LPMel group (11.4 mut/Mb), although there was substantial overlap. In examining characteristic secondary genomic alterations (GA), we found that the frequencies of GA in TERTp, CDKN2A, TP53, and PTEN were significantly lower in the HPMel cases than in LPMel. A higher rate of GA in CTNNB1, APC, PRKAR1A, and KIT was identified in the HPMel cohort compared with LPMel. In this study, we quantified the failure rates of melanoma samples for PD-L1 testing due to high melanin pigmentation and showed that CGP can be used in these patients to identify biomarkers that can guide treatment decisions for HPMel patients. Using this practical clinical definition for tumor pigmentation, our results indicate that HPMel are frequent at 13% of melanoma samples, and in general appear molecularly less developed, with a lower TMB and less frequent secondary GA of melanoma progression. © The Author(s) 2022. Published by Oxford University Press.

Citation

Richard S P Huang, Julie Y Tse, Lukas Harries, Ryon P Graf, Douglas I Lin, Karthikeyan Murugesan, Matthew C Hiemenz, Vamsi Parimi, Tyler Janovitz, Brennan Decker, Eric Severson, Mia A Levy, Shakti H Ramkissoon, Julia A Elvin, Jeffrey S Ross, Erik A Williams. Variable Genomic Landscapes of Advanced Melanomas with Heavy Pigmentation. The oncologist. 2022 Aug 05;27(8):655-662